GlobeNewswire by notified

BIGBEN: PRESS RELEASE: Q3 2022-23 SALES: 79.5 M€

Share

                                                Press release

           Lesquin, 23 January 2023, 18:00 hrs

Q3 2022-23SALES: 79.5 M€
2022-23 CUMULATIVE SALES (9 months):218.1 M€

BIGBEN INTERACTIVE (ISIN FR0000074072) today released its consolidated sales for the first 9 months of its Financial Year 2022-23 (from April 1, 2022 to December 31, 2022) as approved by its Board of directors on 23 January 2023.

IFRS – M€2022-23

2021-22

Change in %

Sales
1st Half-year (April - Sept.)138.6124.2+11.6%
Nacon Gaming77.573.0+6.2%
Bigben Audio / Telco61.151,2+19.3%
3rdQuarter (Oct. - Déc.) (1)79.591.3-12.8%
Nacon Gaming41.151.2-19.6%
Bigben Audio / Telco38.440.1-4.1%
Cumulative 9 months (Apr.Dec.) (1)218.1215.4+1.2%
Nacon Gaming118.7124.2-4.5%
Bigben Audio / Telco99.491.2+9.0%

(1)   Non audited data

Q3 2022-23 sales : 79.5 M€

NACON Gaming posted 41.1 M€ sales in Q3 2022-23. Over the period, sales of video games and accessories were impacted by the worldwide shortage of consoles and drastic stock management by distributors.

VIDEO GAMES: Catalogue sales (new games) rose by 17.2% to 10.2 M€. Sales for the quarter were boosted by games released in the first half of the year (VampireThe Masquerade® - Swansong, Pro Cycling Manager 2022 and Tour De France 2022, SteelrisingTM and Session Skate SimTM) and by the release of WRC Generations on 3 November, which outperformed its predecessor, WCR10, in the first two months following release.

The Back catalogue (games released during previous financial years) once again achieved an excellent performance. Its sales were up 59.5% over the quarter to 8.8 M€.

ACCESSORIES: Sales of accessories came to 20.4 M€, down 41.5% over the quarter. Since the beginning of the year, the shortage of new generation consoles has caused a sharp decline in the global accessories market, leading retailers to be very cautious in their sourcing policy.

BIGBEN – Audiovideo/Telco posted 38.4 M€ sales in Q3 2022-23 down 4.1%.

MOBILE ACCESSORIES: This business showed good resistance. Q3 sales amounted to 28.3 M€, compared with 29.0 M€ in Q3 2021-2022.

AUDIO-VIDEO: This business was resilient over the period thanks in particular to the good performance of the Bigben Kids and Bigben Party sound and lighting ranges. Q3 sales amounted to 10.0 M€, compared with 10.8 M€ in Q3 2021-2022.

Over the first nine months of the year, BIGBEN – Audio-Video/Telco sales totalled 99.4 M€. Mobile accessories were up 8.5% at 75.2 M€, boosted by the success of the Force® premium ranges. The Audio-Video business recorded an 11.1% increase to 24.0 M€ partly due to the inclusion of Metronic in the consolidation scope.

Expected trends for the 4th quarter and 2022/23 targets

NACON GAMING

New publishing releases for the 4th quarter will be sustained, with the launch of four games:
- Chef Life and the highly anticipated Blood Bowl®3 will be released on 23 February 2023.
- Clash and Transport Fever 2 Console Edition are scheduled for release on 9 March 2023.

As for Accessories, the end of console shortages should lead to an improvement in sales over the next few months.

BIGBEN AUDIOVIDEO/TELCO

To support the positive momentum of the chargers and cables market, the Telco business launched at the end of December 2022 the first universal high-performance Force® Power charger manufactured in France and equipped with GaN and Power Delivery technologies. This industrial relocation completes the efforts already undertaken in the carbon reduction plan.

The Telco business is continuing to premiumise its offering with the launch last September of the Force® Play range ; its wireless headphones have just been awarded the "Product of the Year 2023" label by consumers.

Finally, Metronic's listing of Audio products in DIY stores in the third quarter of 2022-2023 opens up new commercial prospects.

On the strength of sustained new releases in publishing / newsflow at the end of the financial year for NACON and a sustained dynamic in the Mobile Accessories activity thanks to the extension of the Force® ranges, the BIGBEN Group is confident in its ability to generate, for the whole FY 2022-2023, sales and current operating income that are up on the previous financial year.

Strong growth ambition for FY 2023-2024

In FY 2023-2024, NACON will have a wide range of new releases with about twenty games to be launched during the year, including:
- The Lord of the Rings GollumTM, which will be released in the first half of FY 2023-24,
- RoboCop: Rogue City,
- Gangs of Sherwood,
- TestDriveUnlimited Solar Crown.

At the same time, the games released in FY 2022-23 will feed the back catalogue and will mechanically accelerate growth.

The Gaming Accessories market should rebound thanks to a growing installed base of new generation consoles and a more favourable base effect.

Bigben Audio-Video/Telco's business will benefit from favourable market trends for its development with the new ranges of smartphones sold without chargers and pedestrian kits. At the same time, a diversification of sales channels will be actively pursued in order to penetrate the refurbished smartphone market

Given the sustained growth expected for NACON Gaming and a BIGBEN Audio-Video/Telco business that should remain buoyant in FY 2023-2024, the Group anticipates strong growth as of next year and reaffirms its confidence in its medium-term prospects.

Next event:

Q4 2022-2023 sales, 24 April 2023,

Press release after close of the Euronext Paris stock exchange

SALES 2021-22
275.7 M€



HEADCOUNT
Over 1200 employees



INTERNATIONAL
31 subsidiaries and a distribution network
in more than 100 countries
www.bigben-group.com


Bigben Interactive is a European player in video game development and publishing, in design and distribution of smartphone and gaming accessories as well as in audio products. The Group, which is recognized for its capacities in terms of innovation and creativity, intends to become one of Europe’s leaders in each of its markets
Company listed on Euronext Paris, compartment B – Index : CAC Mid & Small – Eligible SRD long
ISIN : FR0000074072 ; Reuters : BIGPA ; Bloomberg : BIGFP
PRESS CONTACTS
CapValue – Gilles Broquelet gbroquelet@capvalue.fr - +33 1 80 81 50 01

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease8.2.2023 22:01:00 CET | Press release

The two induction cohorts missed the co-primary endpoints of clinical remission and endoscopic response at Week 10In the maintenance phase, filgotinib 200mg once daily achieved the co-primary endpoints of clinical remission and endoscopic response at Week 58The safety findings were generally consistent with the known profile of filgotinib in rheumatoid arthritis (RA) and ulcerative colitis (UC)Galapagos decided not to submit a Marketing Authorization Application in Europe based on these topline dataGalapagos remains fully committed to filgotinib, a JAK1 preferential inhibitor orally administered once daily, and its approved indications, RA and UC, and is on track to start a Phase 3 trial in axial spondyloarthritis (AxSpA) later this year Mechelen, Belgium; 8February2023, 22:01CET; regulated information; Galapagos NV (Euronext & NASDAQ: GLPG) todayannouncedthe topline results from DIVERSITY,a global Phase 3 trial to evaluate the safety and efficacy of filgotinib,100mg or 200mg once dail

X8 AG Submits a Swiss Fintech Licence Application8.2.2023 21:21:16 CET | Press release

X8 AG submitted the application for a Swiss FinTech license according to Art. 1b Banking Act with the intention of operating a regulated global stablecoin system BAAR, Switzerland, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The X8 AG team has successfully submitted the application to FINMA, the Swiss Financial Market Supervisory Authority, for the Swiss FinTech license according to Article 1b Banking Act. This marks an important step for X8 AG on its way to become a fully regulated global stablecoin system and significantly differentiating itself from the current non-regulated crypto space. Switzerland offers one of the most advanced regulatory frameworks for digital assets. X8 AG believes that designing its stablecoin system under Swiss law is the best starting point to achieve a global X8 cross-border framework for payments. Full compliance with the Swiss regulatory framework strengthens the high standards of protection for clients. X8 AG aims to empower users and their money with frictionles

GN Store Nord announces intention to initiate a rights issue8.2.2023 20:08:16 CET | Press release

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL This announcement does not constitute an offering memorandum or a prospectus as defined by Regulation (EU) No. 2017/1129 of 14 June 2017. The offer to acquire securities pursuant to the offering is made, and any investor should make their investment decision, solely on the basis of information that is contained in the prospectus to be made generally available in Denmark in connection with the offering. GN Store Nord announces intention to initiate a rights issue In accordance with our announcement on November 11, 2022, GN has conducted a comprehensive review of the appropriate capital structure. In light of the current macroeconomic environment and GN’s leverage, GN announces today that it intends to raise gross proceeds of DKK 7 billion in the first half

Nokia Corporation: Repurchase of own shares on 08.02.20238.2.2023 20:00:00 CET | Press release

Nokia Corporation Stock Exchange Release 8 February 2023 at 21:00 EET Nokia Corporation: Repurchase of own shares on 08.02.2023 Espoo, Finland – On 8 February 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL282,2294.39CEUX20,3804.39AQEU6,3784.39TQEX5,0134.38Total314,0004.39 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023

Interim report 2022/23 - 15% revenue growth and DKK 145 million operating profit (+25%) for the first half following a challenging second quarter8.2.2023 18:57:07 CET | Press release

ANNOUNCEMENT NO. 234 9 February 2023 Interim report for the first half of 2022/23 15% revenue growth and DKK 145 million operating profit (+25%) for the first half following a challenging second quarter Steen Søndergaard, CEO: “Following a very satisfactory 2021/22 with historically high revenue and operating profit growth rates, revenue for the first half of 2022/23 unfortunately disappointed, despite 15% growth. Second quarter sales of instruments, particularly in the North American market, were challenged by a generally more subdued investment sentiment in our primary business segment, cell-based therapy. Our order intake was mainly impacted by weakened demand from capital-sensitive development companies. On the other hand, we saw continued satisfactory growth in sales of consumables and services. Despite the unfavourable market conditions, our earnings continued to grow. While our market is currently affected by the prevailing macroeconomic environment, we have a strong underlying